Following the visits, SHM consultants provide participants with a written report of findings and recommendations. Participants also receive one follow-up telephone consultation, which will occur 60-90 days after the visit.
SHM On-site Consultation Program visits will be available starting in May 2007, though interested parties are encouraged to apply early; enrollment is limited, and available slots are expected to fill quickly.
Which Option Is Right for You?
SHM welcomes participation from hospitalists who work in all types of facilities (large and small community hospitals, academic medical centers, public hospitals, and others) and all types of practice settings, including acute care hospitals, skilled nursing facilities, and rehabilitation hospitals. Both VTE Prevention Collaborative programs are appropriate for individuals with all levels of QI experience, from the novice embarking on his or her first QI project to the seasoned QI leader. Individuals who have not yet begun working on a VTE prevention project are encouraged to apply, as are those who wish to expand or improve upon an existing project.
There are no rigid prerequisites for either program, though we expect individuals whose local VTE prevention efforts are already partially developed to derive more benefit from the On-site Consultation option than would an applicant who has yet to start his or her project. Individuals who have not yet begun working on a VTE prevention project are encouraged to apply for the Mentoring Program, which will ensure access to expert assistance during key development and implementation tasks.
How to Apply
Participation in both the Mentoring and On-site Consultation programs is open to hospitalists who are leading proposed or active VTE prevention projects. Participation is free, but enrollment is limited; interested individuals are encouraged to apply early. SHM members can apply to either program by completing the online application available on the VTE Prevention Collaborative Web site: www.hospitalmedicine.org/vte-pc.
Direct questions about VTE Prevention Collaborative programs to [email protected].
References
- Goldhaber SZ, Tapson VF. DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259-262.
- Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J. 2000 Aug;21(16):1301-1336. Comment in: Eur Heart J. 2000 Aug; 21(16): 1289-1290.
- Stein PD, Huang H, Afzal A, et al. Incidence of acute pulmonary embolism in a general hospital: relation to age, sex, and race. Chest. 1999 Oct;116(4):909-913.
- Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998 Mar 23;158(6):585-593.
- Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):338S-400S. Comment in: Chest. 2005 Jun; 127(6):2297-2298.
- Stratton MA, Anderson FA, Bussey HI, et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med. 2000;160:334-340.
- Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med. 1994 Mar 28;154(6):669-677.
- Walker A, Campbell S, Grimshaw J. Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group. Health Bull (Edinb). 1999 Mar;57(2):141-147.